Comparison KS Versus TS

Launched by UNIVERSITÀ DEGLI STUDI DI SASSARI · Apr 24, 2023

Keywords

ClinConnect Summary

This clinical trial is designed to compare the effectiveness of two different dental implant systems. The two systems being studied are called Osstem TS III and Osstem KS. Researchers want to find out which system provides better results for patients who need dental implants to support their teeth. The trial will look at both clinical outcomes (how well the implants work in the mouth) and radiographic outcomes (what the X-rays show about the implants).

To participate in this study, you must be at least 18 years old and have some missing teeth, needing at least two implants. It’s important that the areas where the implants will be placed are healthy enough for the procedure. Smokers are welcome to join, and there are different categories for smoking habits. However, there are several health conditions that could prevent someone from participating, such as certain serious medical issues or infections in the mouth. This trial is not yet recruiting participants, but if you qualify, you can expect to be followed for five years to see how well the implants work over time.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Any partially edentulous patient with partial edentulism, requiring at least two dental implant-supported rehabilitations, being 18 years or older, and able to sign an informed consent. Implant sites must allow the placement of two implants of at least 4 (premolars) or 4.5 (molars) mm of diameter and 8.5 mm of length. Smokers will be included and categorized into: 1) non smokers; 2) moderate smokers (smoking up to 10 cigarettes/day); 3) heavy smokers (smoking more than 11 cigarettes/day). In case of post-extractive sites, they must have been healing for at least 3 months before being treated in the study. Implants can be adjacent.
• Exclusion Criteria:
• • General contraindications to implant surgery.
• • Patients irradiated in the head and neck area.
• • Immunosuppressed or immunocompromised patients.
• • Patients treated or under treatment with intravenous amino-bisphosphonates.
• • Patients with untreated periodontitis.
• • Patients with poor oral hygiene and motivation.
• • Previous guided bone reconstruction at the intended implant sites.
• • Uncontrolled diabetes.
• • Pregnancy or nursing.
• • Substance abuser.
• • Psychiatric problems or unrealistic expectations.
• • Lack of opposite occluding dentition in the area intended for implant placement.
• • Patients with infection and or inflammation in the area intended for implant placement.
• • Patients participating in other studies, if the present protocol cannot be properly adhered to.
• • Patients referred only for implant placement and cannot be followed ant the treating centre.
• • Patients unable to be followed for 5 years.